This page contains the Commissioning decisions documents for the Peninsula Health Technology Commissioning Group.

BNF 11 Eye

• Anti-vascular endothelial growth factors for the treatment of choroidal neovascularisation caused by pathological myopia
• Bevacizumab for the treatment of neovascular (wet) aged related macular degeneration

<<<<< click this link to return to the main PHTCG - Commissioning decisions page <<<<<